These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 28078112)

  • 1. Molecular spectrum of
    Al-Shamsi HO; Jones J; Fahmawi Y; Dahbour I; Tabash A; Abdel-Wahab R; Abousamra AO; Shaw KR; Xiao L; Hassan MM; Kipp BR; Kopetz S; Soliman AS; McWilliams RR; Wolff RA
    J Gastrointest Oncol; 2016 Dec; 7(6):882-902. PubMed ID: 28078112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing-based cohort study.
    Jauhri M; Bhatnagar A; Gupta S; Bp M; Minhas S; Shokeen Y; Aggarwal S
    Tumour Biol; 2017 Feb; 39(2):1010428317692265. PubMed ID: 28222664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Frequency of KRAS Codon 146 and FBXW7 Mutations in Thai Patients with Stage II-III Colon Cancer.
    Korphaisarn K; Pongpaibul A; Roothumnong E; Pongsuktavorn K; Thamlikitkul L; Anekpuritanang T; Poungvarin N; Thongnoppakhun W; Pithukpakorn M
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2319-2326. PubMed ID: 31450901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between mismatch repair protein,
    Fan JZ; Wang GF; Cheng XB; Dong ZH; Chen X; Deng YJ; Song X
    World J Clin Cases; 2021 Apr; 9(11):2458-2468. PubMed ID: 33889611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer.
    Saharti S
    Cureus; 2022 Apr; 14(4):e24392. PubMed ID: 35619874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of KRAS, NRAS, BRAF and PIK3CA gene mutations with clinicopathological features, prognosis and ring finger protein 215 expression in patients with colorectal cancer.
    Wu JB; Li XJ; Liu H; Liu YJ; Liu XP
    Biomed Rep; 2023 Dec; 19(6):104. PubMed ID: 38025833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer patients receiving Bevacizumab: a single institution experience.